Effects of a low-sodium diet in patients with idiopathic hyperaldosteronism: a randomized controlled trial

• Published in: Frontiers in endocrinology (Lausanne) Vol. 14; p. 1124479
• Main Authors: Zhou, Lihua, Jiang, Yiran, Zhang, Cui, Su, Tingwei, Jiang, Lei, Zhou, Weiwei, Zhong, Xu, Wu, Luming, Wang, Weiqing
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 19.04.2023
• Subjects: blood pressure; Diet, Sodium-Restricted; Endocrinology; Female; Humans; Hyperaldosteronism - complications; Hyperaldosteronism - drug therapy; Hypertension - drug therapy; Hypertension - etiology; idiopathic hyperaldosteronism; low sodium diet; Potassium; randomized controlled trial; Sodium; Sodium, Dietary - therapeutic use; blood pressure; low sodium diet; sodium; idiopathic hyperaldosteronism; potassium; randomized controlled trial
• ISSN: 1664-2392; 1664-2392
• DOI: 10.3389/fendo.2023.1124479

Idiopathic hyperaldosteronism (IHA) is one of the most common types of primary aldosteronism (PA), an important cause of hypertension. Although high dietary sodium is a major risk factor for hypertension, there is no consensus on the recommended dietary sodium intake for IHA. This study investigated the effect of a low-sodium diet on hemodynamic variables and relevant disease biomarkers in IHA patients, with the aim of providing a useful reference for clinical treatment. Fifty IHA patients were evenly randomized into two groups and provided, after a 7-day run-in period (100 mmol/d sodium), either a low-sodium diet (50 mmol/d sodium) or a normal sodium diet (100 mmol/d sodium) for an additional 7 days. After the 14-day intervention (conducted without potassium supplementation), changes in blood pressure (BP) and serum potassium were evaluated in both groups. After the dietary intervention, the low sodium group exhibited, compared to the normal sodium group, decreased BP (SBP: 121.8 ± 12.8 . 129.9 ± 12.1 mmHg, p < 0.05; DBP: 82.6 ± 7.6 . 86.4 ± 8.2 mmHg, p < 0.05; MAP: 95.7 ± 8.8 . 100.9 ± 8.4 mmHg, p < 0.05) and increased serum potassium levels (3.38 ± 0.33 . 3.07 ± 0.27 mmol/L, p < 0.001). The low sodium group showed also better control of both BP and serum potassium: BP <140/90 mmHg in 70.0% of total patients (76.0% . 64.0%, in the low and normal sodium groups, respectively; p > 0.05), BP <130/85 mmHg in 38.0% of total patients (56.0% . 20.0%, p < 0.05), BP <120/80 mmHg in 28.0% of total patients (44.0% . 12.0%, p < 0.05); serum potassium ≥3.5 mmol/L in 22.0% of total patients (32.0% . 12.0% in the low and normal sodium groups, respectively; p = 0.088). There were differences between the controlled BP group (<120/80 mmHg) and the non-controlled BP group (≥120/80 mmHg) in gender, BP at baseline, and type of diet (low . normal sodium). Female gender and low-sodium diet were protective factors for BP control. A low-sodium diet is effective in lowering BP and elevating serum potassium in IHA patients. Female patients on a low-sodium diet are more likely to achieve BP control (<120/80 mmHg). We advocate a dietary sodium intake of 50 mmol/d for IHA patients. https://clinicaltrials.gov, Identifier NCT05649631.